| Literature DB >> 30918750 |
Chang Xu1, Yingzhi Lu1, Biye Wang2, Chenglin Zhou1.
Abstract
BACKGROUND: Inhibition processing is sensitive to aging, and an age-related decline in inhibition processing has been associated with an accelerated rate of progression to Alzheimer disease. Elderly women are two to three times more likely than age-matched men to have Alzheimer disease. Therefore, this study examined whether long-term high physical activity affects inhibitory processing, specifically among postmenopausal women.Entities:
Keywords: Event-related potential; Inhibition control; Physical activity; Postmenopausal women
Year: 2019 PMID: 30918750 PMCID: PMC6428037 DOI: 10.7717/peerj.6523
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Screening and grouping the participants.
Baseline data of the participant characteristics (mean ± SD).
| Variables | High active, HA | Control group, CG |
|---|---|---|
| 30 | 30 | |
| Demographic and health data | ||
| Age (year) | 59.83 ± 3.39 | 59.10 ± 4.31 |
| Menopause prior (year) | 9.40 ± 4.27 | 9.20 ± 4.82 |
| BMI (kg/cm2) | 23.86 ± 3.44 | 24.68 ± 3.11 |
| Cognitive score | ||
| MoCA | 26.10 ± 3.02 | 26.07 ± 2.74 |
| SPM | 68.83 ± 18.08 | 69.17 ± 20.47 |
| Physical activity | ||
| Gross MET | 8294.97 ± 2462.64 | 2028.72 ± 540.17 |
| High intensity (METs) | 2022.67 ± 1873.04 | – |
| VPA (min) | 252.83 ± 234.13 | – |
| Moderate intensity (METs) | 4850.00 ± 2425.83 | 1164.67 ± 562.03 |
| MVPA (min) | 1212.50 ± 606.46 | 291.17 ± 140.51 |
| Walking (METs) | 1422.30 ± 990.82 | 864.05 ± 489.09 |
Note:
BMI, body mass index; MET, metabolic equivalent; VPA, value per action; MVPA, moderate to vigorous physical activity.
Figure 2The sequence of events within a single trial of the task.
Figure 3The grand-average ERPs at the Fz, FCz, FC1 and FC2 recording sites.
HA, highly physical activity group; CG, control group.
Behavioral data for the standard Go/Nogo task (mean ± SD).
| Variables | High active | Control group |
|---|---|---|
| Go RT (ms) | 475.04 ± 34.09 | 542.11 ± 63.17 |
| Go accuracy (%) | 99.23 ± 1.70 | 98.20 ± 2.59 |
| Nogo accuracy (%) | 96.87 ± 4.26 | 94.33 ± 6.30 |
Figure 4The amplitudes (A) and latency (B) of N2 and P3 components in response to the go and no-go trials across groups.
The asterisk symbol (*) indicates that the statistical significance was p < 0.05. HA, highly physical activity group; CG, control group.
ERP data (amplitude and latency) for the standard Go/Nogo task (mean ± SD).
| Variables | High active | Control group | ||
|---|---|---|---|---|
| ERP results | Amplitude (μV) | Latency (ms) | Amplitude (μV) | Latency (ms) |
| Go-N2 | ||||
| FZ | −1.84 ± 1.82 | 207.27 ± 44.46 | −1.70 ± 3.05 | 218.30 ± 40.59 |
| FCZ | −1.54 ± 2.17 | 218.63 ± 34.10 | −1.57 ± 2.69 | 227.80 ± 45.62 |
| FC1 | −1.48 ± 2.17 | 202.83 ± 38.29 | −1.18 ± 2.55 | 239.10 ± 61.65 |
| FC2 | −0.90 ± 2.61 | 206.07 ± 38.89 | −1.15 ± 3.07 | 220.43 ± 39.95 |
| Nogo-N2 | ||||
| FZ | −1.99 ± 2.61 | 208.37 ± 41.83 | −1.51 ± 1.96 | 212.83 ± 41.81 |
| FCZ | −1.71 ± 2.20 | 222.40 ± 41.60 | −1.30 ± 1.79 | 229.20 ± 40.74 |
| FC1 | −1.73 ± 2.23 | 207.13 ± 37.92 | −0.94 ± 1.74 | 226.13 ± 31.98 |
| FC2 | −1.08 ± 2.39 | 199.93 ± 38.64 | −0.84 ± 1.96 | 220.40 ± 35.98 |
| Go-P3 | ||||
| FZ | 2.89 ± 2.19 | 398.23 ± 64.03 | 2.74 ± 2.81 | 401.63 ± 61.28 |
| FCZ | 3.97 ± 3.24 | 387.97 ± 54.57 | 2.82 ± 2.92 | 384.67 ± 61.42 |
| FC1 | 3.80 ± 3.26 | 390.63 ± 70.36 | 2.47 ± 2.35 | 396.10 ± 64.78 |
| FC2 | 5.05 ± 2.99 | 383.70 ± 49.60 | 4.36 ± 2.73 | 399.93 ± 54.33 |
| Nogo-P3 | ||||
| FZ | 4.39 ± 3.61 | 424.87 ± 61.26 | 4.81 ± 3.45 | 453.57 ± 57.75 |
| FCZ | 5.62 ± 3.89 | 450.20 ± 45.33 | 5.14 ± 4.02 | 450.30 ± 59.39 |
| FC1 | 5.23 ± 3.73 | 426.63 ± 60.69 | 4.82 ± 3.45 | 450.70 ± 53.33 |
| FC2 | 5.67 ± 3.70 | 422.93 ± 53.62 | 6.63 ± 3.21 | 453.36 ± 56.42 |